by Mark Curtis | Dec 30, 2015
Welcome to your Cell Therapy Deal Review for the month of November. Astellas failed to achieve the majority share it needed to push through a takeover of Ocata Therapeutics valued at $379 million. ImmunoCellular Therapeutics announced a research agreement with MD...
by Mark Curtis | Dec 28, 2015
For those of you that missed ISCT’s recent webinar on manufacturing, needle-to-needle logistics and reimbursement, below is a brief re-cap of the key points on the reimbursement section that I provided. The presentation, including audio, should be available free on...
by Stacey Johnson | Dec 11, 2015
I have yet to meet a parent who doesn’t think reading to/with their kids is crucial. I’m going to assume that if you’re a scientist, instilling a love of science to your children, through books, is a priority. With winter holidays just around the corner, kids will...
by Mark Curtis | Dec 10, 2015
Welcome to your Update from the Clinic for the month of November. There were a number of mid-stage clinical trials launched by cell-based immunotherapy companies this past month, furthering a robust global pipeline of CAR/TCR products. We also saw some efficacy data...
by Stacey Johnson | Dec 4, 2015
Justin Trudeau, Canada’s “hot” new prime minister, is getting Canadian scientists all worked up – in a good way. For the first time in nearly ten years, the scientific community has a passionate champion in Ottawa ready to undress – sorry unmuzzle – federal scientists...
by Nicole Kuchinsky | Dec 1, 2015
November was a big month for science in Canada. Our new prime minister, Justin Trudeau, sent a clear message that science will be a priority for his administration by naming Dr. Kirsty Duncan Minister of Science, and Navdeep Bains Minister of Innovation, Science and...
by Stacey Johnson | Nov 27, 2015
To some people, November is now Movember. That is testament to how successful and pervasive this campaign for men’s health – especially prostate cancer – has become. (Blogger Sara Nolte has also chosen to write about prostate cancer during Movember.) Last month the...
Comments